In contrast, a low expression of SOX11 was frequently observed in other cancers, such as nasopharyngeal carcinoma (NPC) [21], prostate cancer [22], gastric cancer (GC) [23] and bladder cancer [24]. Here, SOX11 is linked to prostate cancer.